Clinical Immunology

Inflammation, autoimmunity, NK cells, gut-immune axis, and evidence-based immune modulation. Understanding your immune system beyond simple 'boosting.'

114 related articles·916 min total reading time
Free Guide

Understanding Your Immune System

Download the complete physician's guide. Evidence-based, no hype.

Get Free Guide →

All Articles

111 articles
CRP and Depression: What Inflammation Testing Reveals Before You Start TMS Immunology

CRP and Depression: What Inflammation Testing Reveals Before You Start TMS

CRP and cytokine testing before TMS for depression identifies the inflamed subtype, predicts response, and guides whether inflammation must be treated first.

Nov 10, 2026 · 9 min
Treatment-Resistant Depression: The Cause-First Workup Before TMS Protocols

Treatment-Resistant Depression: The Cause-First Workup Before TMS

Before treating TRD, investigate the cause: qEEG brain mapping, CRP inflammation testing, Lyme/viral infections, and toxic relationships. Julian's clinical protocol.

Nov 8, 2026 · 9 min
ARA-290 (Cibinetide): Small Trials in Nerve Pain Peptides

ARA-290 (Cibinetide): Small Trials in Nerve Pain

ARA-290 (cibinetide) is an EPO-derived peptide tested in small trials for sarcoidosis and diabetic small fiber neuropathy. Doses, results and limits.

Oct 23, 2026 · 9 min
Crystagen (EDP): Immune Bioregulator With Almost No Data Peptides

Crystagen (EDP): Immune Bioregulator With Almost No Data

Crystagen (Glu-Asp-Pro) is a Khavinson Cytogen sold for the immune system. PubMed holds a few cell and docking studies, no human trials. What is known.

Oct 23, 2026 · 5 min
Thymogen (Glu-Trp): Russian Drug, Failed Western Trial Peptides

Thymogen (Glu-Trp): Russian Drug, Failed Western Trial

Thymogen (Glu-Trp, oglufanide) is a licensed immunostimulant in Russia. The same dipeptide failed a US phase III trial in Kaposi sarcoma. Evidence and doses.

Oct 23, 2026 · 7 min
Thymulin: Zinc-Dependent Thymus Hormone, Thin Human Data Peptides

Thymulin: Zinc-Dependent Thymus Hormone, Thin Human Data

Thymulin is a zinc-dependent thymic nonapeptide that falls with age. Human treatment data are minimal; protocols range 1,000-fold. Evidence, doses, risks.

Oct 23, 2026 · 8 min
Vilon (Lys-Glu): Thymus Dipeptide, Mouse Lifespan Data Peptides

Vilon (Lys-Glu): Thymus Dipeptide, Mouse Lifespan Data

Vilon (Lys-Glu) is a Khavinson thymus dipeptide. Mouse lifespan and tumour studies, cell data and one small diabetes study exist; no controlled human trials.

Oct 23, 2026 · 6 min
Thymic Involution and Immune Aging: Can Peptides Help? Peptides

Thymic Involution and Immune Aging: Can Peptides Help?

The thymus shrinks with age and naive T-cell output falls. What thymosin alpha-1 and the TRIIM study show, and what would count as real proof.

Oct 22, 2026 · 8 min
Thymosin Alpha-1 for Long COVID: Immune Restoration When the Immune System Stays Broken Peptides

Thymosin Alpha-1 for Long COVID: Immune Restoration When the Immune System Stays Broken

How thymosin alpha-1 addresses the core immune dysfunction of long COVID — T-cell exhaustion, NK cell deficiency, and chronic viral persistence — with dosing protocols.

Oct 6, 2026 · 8 min

Your Immune System: A Physician's Guide

In-depth reference by Dr. med. univ. Julian Douwes

Your Immune System: A Physician’s Guide

By Dr. med. univ. Julian Douwes, Chief Medical Officer, St. George Hospital


The immune system is the most sophisticated defense network in biology. It distinguishes self from non-self across trillions of cells, remembers threats it encountered decades ago, and adapts in real time to novel pathogens it has never seen before. It does all of this simultaneously, continuously, without conscious input.

And yet most patients, and many physicians, have only a rudimentary understanding of how it works.

I spend a significant portion of my clinical practice treating patients with immune dysfunction: chronic Lyme disease, post-COVID syndromes, autoimmune conditions, chronic fatigue, recurrent infections, and cancer. What I have learned is that the immune system is rarely doing nothing. When patients are sick, it is almost always doing something: the wrong thing, or the right thing at the wrong time, or in the wrong place. Which of these it is decides the treatment.

This guide explains the immune system the way I explain it to patients in clinic, with enough detail to be useful and without the jargon that makes immunology textbooks impenetrable. Whether you are a patient trying to understand your own condition, a health professional looking for an integrative perspective, or simply someone who wants to understand the system that keeps you alive, this is written for you.


The Architecture of Immunity

Your immune system is a distributed network rather than a single organ. It includes the bone marrow, thymus, spleen, lymph nodes, tonsils, Peyer’s patches in the gut, and circulating white blood cells. Each component has a specific role, and they communicate through an extraordinarily complex signaling network of cytokines, chemokines, and cell-surface receptors.

The functional architecture divides into two broad systems:

Innate Immunity: The First Responders

The innate immune system is ancient, evolutionarily speaking. It is the system we share with insects, plants, and virtually every multicellular organism. It responds within minutes to hours, recognizes broad categories of threat rather than specific pathogens, and does not improve with repeated exposure.

Key players in innate immunity include:

  • Neutrophils: the most abundant white blood cells, first to arrive at sites of infection, effective at killing bacteria but short-lived
  • Macrophages: longer-lived cells that engulf pathogens, present antigens to adaptive immune cells, and orchestrate the inflammatory response
  • Natural killer (NK) cells: specialized in destroying virus-infected cells and cancer cells without prior sensitization
  • Dendritic cells: the bridge between innate and adaptive immunity, responsible for capturing antigens and presenting them to T cells
  • The complement system: a cascade of proteins that can directly destroy pathogens, recruit immune cells, and enhance phagocytosis
  • Physical barriers: skin, mucous membranes, stomach acid, and the intestinal epithelium

The innate system operates on pattern recognition. It does not need to have seen a specific pathogen before. Instead, it recognizes conserved molecular patterns common to broad categories of microorganisms, such as bacterial cell wall components, viral nucleic acids, and fungal polysaccharides. These pattern recognition receptors (particularly toll-like receptors, or TLRs) trigger immediate defensive responses.

Adaptive Immunity: The Precision System

The adaptive immune system is unique to vertebrates and takes days to weeks to mount a full response, but it is extraordinarily specific and creates lasting memory.

Two primary cell types drive adaptive immunity:

  • T cells (matured in the thymus): include helper T cells (CD4+) that coordinate the immune response, cytotoxic T cells (CD8+) that directly kill infected cells, and regulatory T cells (Tregs) that prevent excessive immune activation
  • B cells (matured in bone marrow): produce antibodies, which are protein molecules that bind to specific antigens with remarkable precision

The adaptive system’s power comes from its ability to generate an almost infinite diversity of receptors through a process called V(D)J recombination. Your body can produce antibodies and T cell receptors that recognize virtually any molecular structure, including molecules that do not yet exist in nature. The combinatorial mathematics of receptor generation give a repertoire estimated at over 10^18 possible configurations.

When the adaptive system meets a pathogen for the first time, the response is slow: five to seven days for a primary immune response. But a subset of activated cells become memory cells that persist for years or decades. The second encounter with the same pathogen triggers a response that is faster, stronger, and more targeted. This is the principle behind vaccination.


The Immune System in Communication

One of the most important ideas in modern immunology is that the immune system is a communication system as much as a defense force.

Cytokines: The Immune Language

Cytokines are signaling proteins that immune cells use to communicate with each other and with virtually every other tissue in the body. The cytokine network is why immune dysfunction produces symptoms that seem unrelated to immunity: fatigue, brain fog, mood changes, pain sensitivity.

Key cytokine categories include:

  • Pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha, IFN-gamma): amplify the immune response, promote inflammation, signal the brain to produce sickness behavior (fatigue, reduced appetite, social withdrawal)
  • Anti-inflammatory cytokines (IL-10, TGF-beta, IL-4): resolve inflammation, promote tissue repair, prevent autoimmune responses
  • Th1/Th2/Th17/Treg balance: different T helper cell subtypes produce different cytokine profiles, and the balance between them determines whether the immune response is cell-mediated (Th1), antibody-mediated (Th2), inflammatory (Th17), or regulatory (Treg)

In my clinical experience, the patients who struggle most are those whose cytokine signaling has become chronically dysregulated, with persistently elevated pro-inflammatory cytokines and too little anti-inflammatory counterbalance. This is the signature of chronic inflammation, and it underlies conditions ranging from autoimmunity to post-COVID syndrome to cancer-related fatigue.


Where the Immune System Lives

The Gut: 70% of Immune Tissue

Approximately 70% of the body’s immune tissue resides in the gastrointestinal tract, in the gut-associated lymphoid tissue (GALT). This makes anatomical sense: the gut is the largest surface area exposed to the external environment, and it must constantly distinguish between harmless food antigens, beneficial commensal bacteria, and genuine pathogens.

The relationship between the gut microbiome and immune function is bidirectional. The microbiome educates the immune system during early development, teaching it what to tolerate and what to attack. In return, the immune system shapes the microbiome, selectively promoting beneficial species and controlling potentially harmful ones.

When this relationship breaks down through antibiotic overuse, dietary changes, chronic stress, or infection, the consequences extend far beyond digestive symptoms. Gut dysbiosis has been linked to autoimmune disease, allergic disease, metabolic syndrome, and neurological conditions through well-characterized immunological mechanisms.

The Thymus: Immune Education

The thymus gland, located behind the sternum, is where T cells mature and undergo selection. During this process, T cells that react too strongly to self-antigens are eliminated (negative selection), while those that can recognize foreign antigens effectively are allowed to mature (positive selection).

The thymus begins involuting (shrinking) after puberty, and by age 50, most thymic tissue has been replaced by fat. This thymic involution is one of the main reasons immune function declines with age: the supply of new, naive T cells diminishes, and the immune system increasingly relies on existing memory T cells. This has implications for both infection susceptibility and cancer surveillance.

Thymic peptides, particularly thymulin and thymosin alpha-1, have been studied as a means of partially restoring thymic function. Thymosin alpha-1 is licensed in some countries outside the US and EU for immune modulation; it is not FDA- or EMA-approved. Thymic peptide therapy is one of several tools used to support immune function in patients with age-related immune decline or chronic infection.

Bone Marrow: The Factory

All blood cells, including immune cells, originate from hematopoietic stem cells in the bone marrow. The bone marrow produces approximately 500 billion blood cells daily, including neutrophils, monocytes, lymphocyte precursors, and platelets. Nutritional status, toxin exposure, chronic infection, and aging all affect bone marrow function, and by extension, immune cell production.


Immune Dysfunction: What Goes Wrong

In clinical practice, immune dysfunction falls into several broad categories:

1. Immunodeficiency: Not Enough Response

Primary immunodeficiency diseases are genetic and relatively rare. Secondary immunodeficiency, caused by malnutrition, chronic infection, medications, stress, or aging, is far more common and frequently underdiagnosed.

Signs that warrant investigation include recurrent infections (more than three to four per year requiring antibiotics), infections that are unusually severe or slow to resolve, and opportunistic infections that a healthy immune system would control.

2. Autoimmunity: Misdirected Response

Autoimmune disease occurs when the immune system attacks the body’s own tissues. There are over 80 recognized autoimmune conditions, and their prevalence is increasing in industrialized nations. Genetics alone cannot explain that trend, and environmental factors are almost certainly driving it.

The mechanisms are complex and involve molecular mimicry (pathogens sharing structural similarities with self-antigens), loss of regulatory T cell function, gut barrier dysfunction (allowing bacterial products to enter the bloodstream and trigger immune activation), and chronic infection driving persistent immune stimulation.

3. Chronic Inflammation: Stuck in the “On” Position

Chronic, low-grade inflammation is arguably the most common form of immune dysfunction I see in clinical practice. It is a state rather than a disease, and it predisposes to virtually every chronic disease: cardiovascular disease, neurodegenerative disease, cancer, metabolic syndrome, depression.

The drivers are well characterized: visceral adiposity, gut dysbiosis, chronic infections (including dental infections), environmental toxin exposure, chronic psychological stress, sleep deprivation, and a pro-inflammatory diet. The solution is rarely a single intervention. It requires addressing multiple drivers simultaneously.

4. Immune Exhaustion: Worn Out by Chronic Stimulation

This is a pattern I see frequently in chronic Lyme disease and post-COVID patients. The immune system has been fighting a chronic infection or persistent inflammatory stimulus for so long that its cells become functionally impaired. T cells upregulate exhaustion markers (PD-1, LAG-3, TIM-3) and lose their ability to mount effective responses. NK cell activity declines. The patient becomes simultaneously over-inflamed and under-defended.

This is where integrative approaches have particular value. Conventional medicine has limited tools for immune exhaustion outside of oncology (where checkpoint inhibitor therapy addresses similar mechanisms). Integrative approaches, including IV therapies, hyperthermia, thymic peptides, and targeted nutritional support, offer additional options for restoring immune cell function.


An Integrative Approach to Immune Health

Here is what I tell my patients about maintaining immune function. Treat it as a framework for thinking about immune health rather than a protocol:

Foundation (strongest evidence):

  • Sleep: 7-9 hours, consistent timing. Sleep deprivation for even a single night reduces NK cell activity by approximately 70% (human data, Irwin et al.), so sleep comes first.
  • Exercise: moderate, regular physical activity enhances immune surveillance. Excessive exercise without adequate recovery can be immunosuppressive.
  • Nutrition: adequate protein (essential for antibody and immune cell production), micronutrient sufficiency (zinc, selenium, vitamin D, vitamin C, vitamin A), and a diverse plant-rich diet that supports gut microbial diversity.
  • Stress management: chronic cortisol elevation suppresses cellular immunity while promoting inflammatory pathways. The data on this is Level 1.

Targeted support (moderate to strong evidence):

  • Vitamin D: 25(OH)D levels below 30 ng/mL are associated with impaired immune function. The relationship between vitamin D and immune regulation is supported by extensive human data. Target 40-60 ng/mL.
  • Zinc: essential cofactor for over 300 enzymes including those critical for immune cell function. Deficiency is common, particularly in older adults, and impairs both innate and adaptive immunity. Supplementation at 15-30 mg daily is reasonable for most adults.
  • Gut health: the connection between gut integrity, microbiome diversity, and immune function is one of the most important themes in modern medicine. Address it.

Advanced interventions (clinical context required):

  • IV therapies: high-dose intravenous vitamin C, glutathione, and micronutrient formulations can provide pharmacological effects not achievable through oral supplementation. In my practice, these are used in the context of specific clinical indications, not as general wellness measures.
  • Immune modulation therapies: hyperthermia, thymic peptides, mistletoe extract (Viscum album), and other modalities that modulate immune function. These require physician supervision and are tailored to individual patient needs.
  • Functional diagnostics: lymphocyte subset panels, NK cell function testing, cytokine profiling, and other assessments that provide a detailed map of immune function beyond what a standard CBC offers.

The Honest Uncertainties

I want to be transparent about what we do not fully understand:

The immune system is the most complex biological system we have attempted to characterize, and our understanding remains incomplete. We do not fully understand why some people develop autoimmune disease and others do not, even when exposed to the same environmental triggers. We cannot reliably predict which post-COVID patients will develop long-term immune dysregulation. We do not have a comprehensive model for how the hundreds of identified cytokines interact in vivo.

What we do have is a sophisticated and growing understanding of immune function that allows us to make evidence-based clinical decisions for most patients most of the time. The gap between what immunology knows in the laboratory and what clinical medicine applies at the bedside remains significant but is narrowing, and integrative medicine at its best works in that gap.


Where to Go From Here

This article provides a framework. The specific topics are explored in depth across this series:

Understanding your immune system is the foundation for understanding your health, your disease, and the reasoning behind the treatments your physicians recommend. The more you understand, the better the conversations you can have with your medical team, and the better decisions you can make about your own care.


Disclaimer: This article is provided for educational purposes and reflects one physician’s clinical perspective. It is not a substitute for individualized medical care. Consult a qualified physician before making decisions about your health based on this information.

The Evidence Brief

Stay ahead of the research.

Weekly deep dives on clinical immunology and beyond. Written for physicians, researchers, and patients.

Email only, no medical details needed. Privacy policy.